The mother of 16-year-old, Alexander "AJ" Betts Jr., who died from attempted suicide, was shocked to find out that her son's eyes were ineligible for donation because of his sexual orientation.
Researchers have identified the immune cells responsible for destroying hair follicles in patients with alopecia areata, according to a study. They also tested an FDA-approved drug that eliminated these immune cells and restored hair growth in patients.
Federal regulators have approved the speciality drug-maker Biogen Idec's new treatment for people with relapsing forms of multiple sclerosis.
The FDA has approved a new prescription pill for insomnia.
The popular Colgate Total toothpaste contains the ingredient, Triclosan, which has been linked to cancer.
The FDA is warning people to double check tattoo ink bottles due to concerns about potential infections linked to contaminated ink.
The FDA's regulation on using the "gluten-free label" has gone into effect this Tuesday.
Amgen Inc. announced that its blood cancer drug was capable of extending the lives of patients suffering from multiple myeloma.
Johnson & Johnson is once again reminding doctors to steer clear of certain medical tools used to perform a hysterectomy or fibroid-removal surgery.
Decorative contact lenses are fun accessory but if not paid serious attention to, they can cause serious eye damage.
The 2nd U.S. Circuit Court of Appeals ruled that the FDA is not legally required to hold public hearings when evaluating the potential health risks involved with using antibiotics in animal feed.
The FDA has approved a new combination painkiller that is more difficult to abuse.
The FDA will "consider taking regulatory action" on powdered caffeine after a healthy teen died from an overdose.
There is little to no evidence that a popular technique for removing fibroids can be performed without the risk of spreading undetected cancers to other parts of the body, according to FDA health advisers.
Smallpox vials were discovered inside an old storage area in Bethesda, MD.
Researchers from the University of Sheffield School of Health and Related Research (ScHARR) are today making a series of recommendations for NHS mental health trusts to change the way they collect and use patient feedback to improve the quality of care for inpatients.